We are live on ! Find out more
APGN

Apexigen, Inc. Common Stock
APGN

Delisted

APGN was delisted on the 22nd of August, 2023.

Back to rankings

30 hedge funds and large institutions have $22.2M invested in Apexigen, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

58% more funds holding

Funds holding: 19 → 30 (+11)

29% more capital invested

Capital invested by funds: $17.3M → $22.2M (+$4.96M)

Holders
30
Holders Change
+11
Holders Change %
+57.89%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$991K
2
BCM
Basso Capital Management
Connecticut
+$915K
3
KIM
Karpus Investment Management
New York
+$742K
4
KC
Kepos Capital
New York
+$454K
5
CM
Crestline Management
Texas
+$406K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17K
2
HI
Harbour Investments
Wisconsin
-$5.82K
3
UBS Group
UBS Group
Switzerland
-$991
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
1
Periscope Capital
Ontario, Canada
$4.14M – – –
FTCM
2
Fir Tree Capital Management
New York
$2.97M – – –
KIM
3
Karpus Investment Management
New York
$2.04M +$742K +74,881 +57%
Tudor Investment Corp
4
Tudor Investment Corp
Connecticut
$1.99M – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$1.39M – – –
BCM
6
Basso Capital Management
Connecticut
$1.32M +$915K +92,412 +228%
RCM
7
Radcliffe Capital Management
Pennsylvania
$1.31M – – –
RCM
8
Rivernorth Capital Management
Florida
$992K – – –
CH
9
CVI Holdings
Delaware
$990K +$991K +100,000 New
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$751K – – –
Jane Street
11
Jane Street
New York
$738K +$162K +16,359 +28%
WRBC
12
W.R. Berkley Corp
Connecticut
$546K – – –
KC
13
Kepos Capital
New York
$455K +$454K +45,826 New
CM
14
Crestline Management
Texas
$406K +$406K +40,961 New
BI
15
Bulldog Investors
New Jersey
$374K – – –
WAM
16
Wolverine Asset Management
Illinois
$366K +$75.7K +7,647 +26%
Millennium Management
17
Millennium Management
New York
$351K +$351K +35,389 New
WAM
18
Weiss Asset Management
Massachusetts
$259K +$259K +26,154 New
LCM
19
Landscape Capital Management
New Jersey
$208K +$208K +20,987 New
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
$169K – – –
HI
21
Harbour Investments
Wisconsin
$158K -$5.82K -587 -4%
GCIA
22
Gabelli & Co Investment Advisers
New York
$110K +$110K +11,100 New
GF
23
Gabelli Funds
New York
$102K +$101K +10,229 New
DMK
24
David M. Knott
$40K – – –
PAM
25
Panagora Asset Management
Massachusetts
$34K +$33.5K +3,386 New
1
2

APGN Hedge Fund Activity: Q2 2021 in Review

30 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q2 2021, worth a combined $22.2M — up 29% from $17.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new APGN positions and 1 closed out — a net gain of 11 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $991K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $17K sold.

  • 30 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q2 2021, up from 19 in Q1 2021.
  • Funds reported $22.2M of Apexigen, Inc. Common Stock stock for Q2 2021, up 29% quarter-over-quarter.
  • 12 funds opened new Apexigen, Inc. Common Stock positions in Q2 2021 and 1 closed out, a net change of +11 holders.
  • The largest Apexigen, Inc. Common Stock buyer in Q2 2021 was CVI Holdings, an estimated $991K added.
  • The largest Apexigen, Inc. Common Stock seller in Q2 2021 was Royal Bank of Canada, an estimated $17K sold.

Based on aggregated 13F filings for Q2 2021.